Merck
MRK
$9,891
Share price
-1.93%
Change (1 day)
20.94%
Change (1 year)
Earnings for Merck (MRK)
Earnings in 2025 (TTM): $2.000 Trillion
According to Merck's latest financial reports the company's current earnings are $64.23 Billion. In 2024 the company made an earning of $1.927 Trillion, an increase over its 2023 earnings that were of $275.82 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Merck from 1984 to 2025
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2025 (TTM)  | $2.000 T | 3.77% |
| 2024 | $1.927 T | 598.75% |
| 2023 | $275.82 B | -82.56% |
| 2022 | $1.581 T | 18.52% |
| 2021 | $1.334 T | 80.8% |
| 2020 | $738.23 B | -34.26% |
| 2019 | $1.122 T | 30.45% |
| 2018 | $860.83 B | 30.2% |
| 2017 | $661.16 B | 35.93% |
| 2016 | $486.40 B | -11.87% |
| 2015 | $551.92 B | -66.29% |
| 2014 | $1.637 T | 183.88% |
| 2013 | $576.73 B | -32.87% |
| 2012 | $859.19 B | 17.32% |
| 2011 | $732.32 B | 240.11% |
| 2010 | $215.31 B | -84.96% |
| 2009 | $1.431 T | 66.09% |
| 2008 | $861.81 B | 68.8% |
| 2007 | $510.55 B | 52.38% |
| 2006 | $335.04 B | -37.16% |
| 2005 | $533.16 B | -11.41% |
| 2004 | $601.84 B | -20.89% |
| 2003 | $760.76 B | -11.74% |
| 2002 | $861.95 B | -2.51% |
| 2001 | $884.12 B | 7.03% |
| 2000 | $826.04 B | 19.69% |
| 1999 | $690.16 B | 19.1% |
| 1998 | $579.46 B | 12.52% |
| 1997 | $514.98 B | 13.68% |
| 1996 | $453.01 B | 13.19% |
| 1995 | $400.21 B | -0.03% |
| 1994 | $400.33 B | 13.36% |
| 1993 | $353.14 B | 11.29% |
| 1992 | $317.31 B | 12.28% |
| 1991 | $282.61 B | 17.29% |
| 1990 | $240.96 B | |
| 1988 | $169.65 B | 36.34% |
| 1987 | $124.43 B | 31.5% |
| 1986 | $94.62 B | 23.98% |
| 1985 | $76.32 B | 5.4% |
| 1984 | $72.41 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $1.077 T | -48.67% | ๐บ๐ธ USA |
 Johnson & Johnson JNJ | $2.944 T | 40.30% | ๐บ๐ธ USA |
 Eli Lilly LLY | $2.045 T | -2.54% | ๐บ๐ธ USA |
 Bristol-Myers Squibb BMY | $730.05 B | -65.21% | ๐บ๐ธ USA |
 Sanofi SNY | $827.04 B | -60.59% | ๐ซ๐ท France |
 GSK plc GSK | $847.28 B | -59.62% | ๐ฌ๐ง UK |
 Teva Pharmaceutical Industries TEVA | $161.04 B | -92.33% | ๐ฎ๐ฑ Israel |
 Novartis NVS | $1.492 T | -28.89% | ๐จ๐ญ Switzerland |
 Abbott Laboratories ABT | $739.59 B | -64.76% | ๐บ๐ธ USA |
 Amgen AMGN | $749.23 B | -64.30% | ๐บ๐ธ USA |